Statement Of Cash Flows [Abstract]
| Concept |
2022-01-01 to 2022-12-31 |
2021-01-01 to 2021-12-31 |
|---|---|---|
| Statement of cash flows [abstract] | ||
| Cash flows from (used in) investing activities [abstract] | ||
| Purchase of interests in investments accounted for using equity method |
—
EUR
|
1,000,000
EUR
|
| Cash advances and loans made to related parties |
—
EUR
|
1,000,000
EUR
|
| Purchase of biological assets |
49,000,000
EUR
|
45,000,000
EUR
|
| Proceeds from sales or maturity of financial instruments, classified as investing activities |
5,000,000
EUR
|
—
EUR
|
| Cash flows from (used in) financing activities [abstract] | ||
| Dividends paid to equity holders of parent, classified as financing activities |
321,000,000
EUR
|
298,000,000
EUR
|
| Dividends paid to non-controlling interests, classified as financing activities |
9,000,000
EUR
|
6,000,000
EUR
|
| Cash flows from (used in) increase (decrease) in current borrowings |
9,000,000
EUR
|
4,000,000
EUR
|